LDLR and familial hyperaldosteronism: Furthermore, in vivo AAV-CRISPR/Cas9-mediated LDLR gene editing partially rescued LDLR expression, reduced TC, total TG, and LDL-cholesterol level and effectively ameliorated atherosclerosis phenotypes in mouse models of FH [96].